Page last updated: 2024-08-17

lysine and ro 28-2653

lysine has been researched along with ro 28-2653 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bertholet, P; Castagne, D; Chiap, P; Delattre, L; Evrard, B; Foidart, JM; Frankenne, F; Piel, G; Piette, M	1

Other Studies

1 other study(ies) available for lysine and ro 28-2653

Article	Year
Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2006, Volume: 28, Issue:3 Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Chemistry, Pharmaceutical; Excipients; Injections, Intravenous; Lysine; Matrix Metalloproteinase Inhibitors; Piperazines; Protease Inhibitors; Pyrimidines; Sheep; Solubility; Solutions; Suspensions	2006

Article

Year

Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2006, Volume: 28, Issue:3

Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Chemistry, Pharmaceutical; Excipients; Injections, Intravenous; Lysine; Matrix Metalloproteinase Inhibitors; Piperazines; Protease Inhibitors; Pyrimidines; Sheep; Solubility; Solutions; Suspensions

2006